Related Experiment Video
Updated: Apr 15, 2026

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
Published on: November 1, 2019
Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling
Xiaolei Shi1, Zhenyang Zheng1, Jie Li2
1Guangdong Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China.
Abstract:
Amyloid β (Aβ) plays an important role in Alzheimer's disease (AD) by inducing microglia activation. Once activated, microglial cells promote the release of reactive species and cytokines that are known to enhance immune responses in AD brain. Thus, negative regulators of microglia activation are considered as potential therapeutic candidates for AD. Curcumin, the major yellow pigment in turmeric (Curcuma longa), is proposed for its anti-inflammatory properties. Several studies have indicated the suppressive effects of curcumin on LPS-induced microglia activation and MAPK activities. However, the effects of curcumin on Aβ-treated microglia and the possible mechanisms are still not fully understood. In the present study, we found that curcumin improved microglial viability against Aβ42 in a time- and dose-dependent manner and remarkably suppressed Aβ42-induced CD68 expression. Moreover, curcumin concentration-dependently abolished Aβ42-induced interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) production in mRNA and protein levels in microglia. Besides, curcumin exerted an inhibitory effect on phosphorylation of ERK1/2 and p38 in Aβ42-activated microglia. Further experiments indicated that blockage of ERK1/2 and p38 pathways reduced inflammatory cytokines production from microglia. These results show that curcumin suppresses ERK1/2 and p38 signaling, thus, attenuating inflammatory responses of brain microglia.
Insights
Curcumin, an anti-inflammatory compound, protects brain cells from Alzheimer's disease pathology by reducing harmful microglial activation and inflammatory responses. It inhibits key signaling pathways involved in neuroinflammation.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Amyloid β (Aβ) peptides trigger microglia activation, a key factor in Alzheimer's disease (AD) neuroinflammation.
- Microglia release inflammatory mediators, exacerbating AD pathology.
- Curcumin, derived from turmeric, exhibits anti-inflammatory properties, but its effects on Aβ-induced microglia activation require further investigation.
Purpose of the Study:
- To investigate the protective effects of curcumin against Aβ42-induced microglia activation.
- To elucidate the underlying molecular mechanisms of curcumin's action in Aβ-treated microglia.
Main Methods:
- Primary microglia cultures were treated with Aβ42 and varying concentrations of curcumin.
- Microglial viability, CD68 expression, and production of inflammatory cytokines (IL-1β, IL-6, TNF-α) were assessed.
- Western blotting was used to analyze the phosphorylation status of ERK1/2 and p38 MAPK pathways.
Main Results:
- Curcumin enhanced microglial viability and suppressed Aβ42-induced CD68 expression.
- Curcumin significantly reduced Aβ42-induced production of IL-1β, IL-6, and TNF-α at both mRNA and protein levels.
- Curcumin inhibited the phosphorylation of ERK1/2 and p38 pathways in Aβ42-activated microglia.
Conclusions:
- Curcumin demonstrates neuroprotective effects by mitigating Aβ42-induced microglial activation and inflammation.
- Curcumin attenuates neuroinflammation by suppressing the ERK1/2 and p38 signaling pathways.
- Curcumin represents a potential therapeutic agent for Alzheimer's disease by modulating microglial inflammatory responses.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

